172 related articles for article (PubMed ID: 1530658)
1. Increase in rat brain glutathione following intracerebroventricular administration of gamma-glutamylcysteine.
Pileblad E; Magnusson T
Biochem Pharmacol; 1992 Sep; 44(5):895-903. PubMed ID: 1530658
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular administration of L-buthionine sulfoximine: a method for depleting brain glutathione.
Pileblad E; Magnusson T
J Neurochem; 1989 Dec; 53(6):1878-82. PubMed ID: 2809598
[TBL] [Abstract][Full Text] [Related]
3. Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexene-1-one.
Pileblad E; Magnusson T
Life Sci; 1990; 47(25):2333-42. PubMed ID: 2263161
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
Standeven AM; Wetterhahn KE
Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
[TBL] [Abstract][Full Text] [Related]
5. Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum.
Pileblad E; Magnusson T; Fornstedt B
J Neurochem; 1989 Mar; 52(3):978-80. PubMed ID: 2493072
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
Perry TL; Yong VW; Jones K; Wright JM
Neurosci Lett; 1986 Oct; 70(2):261-5. PubMed ID: 3490637
[TBL] [Abstract][Full Text] [Related]
7. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
Mayer RD; Maines MD
Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
[TBL] [Abstract][Full Text] [Related]
8. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
9. Selective modulation of glutathione in mouse brain regions and its effect on acrylamide-induced neurotoxicity.
Shivakumar BR; Ravindranath V
Biochem Pharmacol; 1992 Jan; 43(2):263-9. PubMed ID: 1739414
[TBL] [Abstract][Full Text] [Related]
10. Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration.
Toffa S; Kunikowska GM; Zeng BY; Jenner P; Marsden CD
J Neural Transm (Vienna); 1997; 104(1):67-75. PubMed ID: 9085194
[TBL] [Abstract][Full Text] [Related]
11. Effect of N-acetyl-cysteine, D-penicillamine and buthionine sulfoximine on glutathione levels and CNS oxygen toxicity in rats.
Lalitha T; Kerem D; Yannai S
Pharmacol Toxicol; 1990 Jan; 66(1):56-61. PubMed ID: 2308909
[TBL] [Abstract][Full Text] [Related]
12. Divergent effects of intravenous GSH and cysteine on renal and hepatic GSH.
Aebi S; Lauterburg BH
Am J Physiol; 1992 Aug; 263(2 Pt 2):R348-52. PubMed ID: 1510173
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
[TBL] [Abstract][Full Text] [Related]
14. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish.
Gallagher EP; Hasspieler BM; Di Giulio RT
Biochem Pharmacol; 1992 May; 43(10):2209-15. PubMed ID: 1350905
[TBL] [Abstract][Full Text] [Related]
15. Modulation of endothelial GSH concentrations: effect of exogenous GSH and GSH monoethyl ester.
Tsan MF; White JE; Rosano CL
J Appl Physiol (1985); 1989 Mar; 66(3):1029-34. PubMed ID: 2708228
[TBL] [Abstract][Full Text] [Related]
16. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
Drew R; Miners JO
Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
[TBL] [Abstract][Full Text] [Related]
17. Modulation of gamma-glutamylcysteine synthetase large subunit mRNA expression by butylated hydroxyanisole.
Borroz KI; Buetler TM; Eaton DL
Toxicol Appl Pharmacol; 1994 May; 126(1):150-5. PubMed ID: 7910420
[TBL] [Abstract][Full Text] [Related]
18. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
Ravindranath V; Boyd MR
Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
[TBL] [Abstract][Full Text] [Related]
19. Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats.
Mizui T; Kinouchi H; Chan PH
Am J Physiol; 1992 Feb; 262(2 Pt 2):H313-7. PubMed ID: 1539690
[TBL] [Abstract][Full Text] [Related]
20. Disposition of glutathione monoethyl ester in the rat: glutathione ester is a slow release form of extracellular glutathione.
Grattagliano I; Wieland P; Schranz C; Lauterburg BH
J Pharmacol Exp Ther; 1995 Feb; 272(2):484-8. PubMed ID: 7853160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
